Delivery Order SPE2DR25D3004-SPE2DR26FXQU2
- Not listed
- The Defense Logistics Agency awarded a $19.3K delivery order to AmerisourceBergen Drug Corp on April 21, 2025, for the supply of Mekinist 2 mg tablets (30-count units). This is a firm fixed-price, non-set-aside contract with a completion date of May 12, 2025, and performance based in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement, particularly supporting...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Mekinist 0.5 mg tablets in quantities of 30s, with a contract ceiling value of $5,701.68 and an ultimate completion date of October 1, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under open competition. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a $16,303.66 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Mekinist 0.5 mg tablets (30-count units) on December 12, 2025, with completion targeted for January 6, 2026. The award, which carries no set-aside designation, represents a competitively awarded delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. This child contract fulfills pharmaceutical supply requirements for...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $9,670.51 on September 9, 2025, for the supply of Mekinist 2 mg tablets in quantities of 30 units. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under open competition. The contract is set to be completed by September 30, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for supply of Mekinist 0.5 mg tablets (30-count units) under a firm fixed-price contract valued at $2,850.83. The award, issued on May 1, 2025, with completion targeted for May 22, 2025, represents a non-competitive delivery order placed against AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 25, 2025, for the supply of Mekinist 2 mg tablets (30-count units) with a ceiling value of $10,191.22. This firm fixed-price delivery order, with an ultimate completion date of December 17, 2025, was competitively awarded without set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, and represents a continuation of the...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of Mekinist 0.5 mg tablets. The contract, which is not set aside, has a ceiling value of $2,589.70 and a completion date of August 9, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded numerous federal contracts to provide a wide range of essential medical commodities, including specialty medications, branded and generic drugs, vaccines, and...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,623.89 firm fixed-price delivery order is for the supply of MEKINIST 2 MG TABLET UU 30S, which are specialty pharmaceutical products. The contract has an ultimate completion date of May 24, 2023. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This is a $8,878.79 firm fixed-price delivery order contract awarded by the Defense Logistics Agency's Medical Supply Chain to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is to provide 4563518616 Mekinist 2 mg tablets, with a completion date of February 23, 2024. This contract is a part of AmerisourceBergen's broader Indefinite Delivery Contract with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which covers a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $9,962.26 on August 19, 2025, for the supply of Mektovi 15 mg tablets (180-count package), with completion scheduled for September 10, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's broader pharmaceutical supply relationship with DLA. The award carries no set-aside designation and will be fulfilled from the vendor's corporate office...
- SPE2DR25D3004Indefinite Delivery Contract
- SPE2DR25D3004-SPE2DR26FXQU2Delivery Order
The Defense Logistics Agency awarded a $19,566.67 firm fixed price delivery order to AmerisourceBergen Drug Corp for 30 tablets of Mekinist 2 mg (a targeted cancer therapy medication) on December 16, 2025, with an ultimate completion date of January 8, 2026. This non-set-aside contract will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems through the Defense Logistics Agency's Medical Supply Chain. The company's SPE2DX prime IDV functions as a comprehensive global pharmaceutical support vehicle enabling the supply of an extensive range of pharmaceutical products and medical supplies—including specialty medications, brand-name and generic drugs, vaccines, and medical devices—to support military healthcare programs worldwide. The contract supports customers including the Defense Health Agency and U.S. Coast Guard, positioning AmerisourceBergen as a key provider within the DLA's pharmaceutical procurement strategy.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $19.6k | 12/15/25 |